A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy
Clinical trial NCT05527912 · UNKNOWN
Trial details
- NCT number
- NCT05527912
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-24
- Primary completion
- 2024-09-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.